盐酸氨溴索注射液联合特布他林雾化治疗支气管扩张的临床效果

Abstract
Figure/Table
References (16)
Related Citation (3)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo observe the clinical efficacy of Ambroxol Hydrochloride combined with Terbutaline in the treatment of bronchiectasis.Methods100 cases of bronchiectasis admitted to our hospital from January 2015 to October 2016 were selected as the research objects,and were randomly divided into the control group and the experimental group,58 cases in each group.The control group was given conventional treatment,including oxygen,antibiotics(infection control),Aminophylline intravenous and inhaled corticosteroids,the observation group was treated by aerosol inhalation of Ambroxol Hydrochloride and Terbutaline suspension on the basis of the control group.The two groups were treated with 7 d,the clinical efficacy,the wheezing subsided time,cough subsided time,chest distress subsided time and lung function related indicators in the two group were observed.ResultsThe total effective rate of the observation group was 90.0%,which was significantly higher than 72.0%of the control group,with significant difference(P＜0.05).The wheezing subsided time,cough subsided time,chest distress subsided time in the observation group was significantly shorter than that in the control group,with significant difference(P＜0.05).The levels of FVC,FEV1and PEF after treatment in the two groups was higher than that before treatment,with significant difference(P＜0.05).The levels of FVC,FEV1 and PEF after treatment in the observation group was significantly higher than that in the control group,with significant difference(P＜0.05).ConclusionAmbroxol Hydrochloride combined with Terbutaline is effective in the treatment of bronchiectasis,and can rapidly improve the symptoms of bronchiectasis,it is worthy of clinical promotion and application

Key words： Ambroxol Hydrochloride Terbutaline Bronchiectasis Clinical effect observation

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIONG Jia-yi
	PENG Xue-fen
	ZHANG Guo-qiang

Cite this article:

XIONG Jia-yi,PENG Xue-fen,ZHANG Guo-qiang. Clinical efficacy of Ambroxol Hydrochloride Injection combined with Terbutaline in the treatment of bronchiectasis[J]. 中国当代医药, 2017, 24(20): 138-140.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I20/138

[13]	周博.布地奈德和盐酸氨溴索雾化吸人佐治毛细支气管炎的疗效观察[J].中园实用医刊，2010，37（14）：31-32.
[14]	许申.氨溴索的临床应用进展[J].临床肺科杂志，2009，14（8）：1053-1054.
[15]	李瑛，廖吕慧，沈四国.溴已新与氨溴索两种不同祛痰方案对毛细支气管炎喘憋的影响[J].中国实用医刊，2010，37（1）：76-77.
[16]	楼文倩，陈拥军.特布他林联合盐酸氨溴索雾化吸入治疗小儿支气管哮喘效果观察[J].中国乡村医药，2014，21（8）：28-29.
[1]	王伟，徐少华.小剂量红霉素治疗稳定期支气管扩张症疗效观察[J].山东大学学报（医学版），2003，41（4）：449-450，458.
[2]	胡克，杨炯，陈雪芹.支气管扩张症患者对沙丁胺醇与溴化异丙托品的反应性[J].中国呼吸与危重监护杂志，2004，3（5）：304-307.
[3]	彭敏.布地奈德联合沙丁胺醇吸入佐治支气管扩张疗效观察[J].临床肺科杂志，2008，13（6）：793-794.
[4]	高雪萍，古群英，贺咏宁.吸入性β2受体激动剂联合盐酸氨溴索治疗支气管扩张症疗效观察[J].山东医药，2007，47（28）：110-111.
[5]	刘晗.硫酸特布他林联合布地奈德雾化吸入治疗支气管扩张的临床疗效观察[D].长春：吉林大学，2013.
[6]	虞东民.盐酸氨澳索治疗支气管扩张症的临床疗效观察[J].中国初级卫生保健，2012，6（2）：22-23.
[7]	黄宝辉.盐酸氨溴索雾化吸入治疗支气管扩张疗效观察[J].药物与临床，2011，8（9）：15-16.
[8]	聂正义.氨澳索的作用机制及临床应用[J].临床肺科杂志，2011，2（9）：37-38.
[9]	江载芳，申昆玲.实用儿科学[M].7版.北京：人民卫生出版社，2002：1199.
[10]	周小建，洪建国.婴幼儿毛细支气管炎与哮喘的关系[J].中国小儿急救医学，2009，16（2）：97-98.
[11]	王亚亭.毛细支气管炎的诊断、治疗和预防[J].实用儿科临床杂志，2008，23（10）：801-802.
[12]	王宏，付玉静.氧气驱动雾化吸人治疗小儿毛细支气管炎的疗效观察[J].吉林医学，2010，31（35）：6618.